December 1, 2019 Comments Off on Dynavax Technologies Corp. (DVAX) Securities Investigation Blog, Current Investigations

Dynavax Technologies Corp. (DVAX) Securities Investigation

Dynavax Technologies Corp. (DVAX) Securities Investigation, featured by Top Securities Fraud Attorneys, The White Law Group

Dynavax Technologies Corp. Investment Losses

Have you suffered losses investing in Dynavax Technologies Corp.? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.

Dynavax Technologies Corp. (DVAX), a biopharmaceutical company, reportedly discovers, develops, and seeks to commercialize products based on immunostimulatory sequences. The Company develops products to treat and prevent allergies, infectious, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways, according to Bloomberg.

Unfortunately for investors, in the past year, the company’s share price has reportedly declined 27%.

The problem with biopharmaceutical stocks such as Dynavax Technologies Corp. is that they typically involve a high degree of risk. The research and development process for pharma companies often involves costly and lengthy clinical testing trials that yield specific data. If the expected data or end points are not met, the stock can drop drastically.

Without a strong understanding of the company and its basic operations, investors may be looking at serious losses.

Investigating Potential Claims

The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk biopharma stocks to investors.

Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.

If you have concerns regarding investment losses in Dynavax Technologies Corp., please call the securities attorneys at The White Law Group for a free consultation at 888-637-5510.

The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.

For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.

 

 

Comments are closed.